Uric acid and fibrinogen: Age-modulated relationships with blood pressure components

Journal of Human Hypertension

Volumn 25, Issue 8, 2011, Pages 476-483

  Leite, M L C ^a  

^a INSTITUTE OF BIOMEDICAL TECHNOLOGIES   (Italy)

Author keywords

aging; blood pressure; fibrinogen; uric acid

Indexed keywords

FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; FIBRINOGEN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; METABOLIC SYNDROME X; PREHYPERTENSION; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

ADULT; AGE FACTORS; AGED; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; FEMALE; FIBRINOGEN; HUMANS; MALE; MIDDLE AGED; URIC ACID;

EID: 79960437815     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2010.89     Document Type: Article

References (52)

1. Lewington S, Clarke R, Qizilbash N, Pero R, Collins R, Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-1913. (Pubitemid 35472129)
2. Franklin SS, Larson MG, Khan SA, Wong ND, Leip EP, Kannel WB et al. Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation 2001; 103: 1245-1249. (Pubitemid 32221347)
3. Darne B, Girerd X, Safar M, Cambien F, Guize L. Pulsatile versus steady component of blood pressure: a cross-sectional analysis and a prospective analysis on cardiovascular mortalily. Hypertension 1989; 13: 392-400. (Pubitemid 19099610)
4. Franklin SS, Gustin W, Wong ND, Larson MG, Weber MA, Kannel WB et al. Hemodynamic patterns of agerelated changes in blood pressure. The Framingham Heart Study. Circulation 1997; 96: 308-315. (Pubitemid 27298437)
5. Feig DI, Kang D-H, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med 2008; 359: 1811-1821.
6. Koenig W. Fibrin(ogen) in cardiovascular disease: an update. Thromb Haemost 2003; 89: 601-609. (Pubitemid 36456957)
7. Kosugi T, Nakagawa T, Kamath D, Johnson RJ. Uric acid and hypertension: an age-related relationship? J Hum Hypertens 2009; 23: 75-76.
8. Lu Z, Dong B, Wu H, Chen T, Zhang Y, Wu J et al. Serum uric acid level in primary hypertension among Chinese nonagenarians/centenarians. J Hum Hypertens 2009; 23: 113-121.
9. Forman JP, Choi H, Curhan GC. Plasma uric acid level and risk for incident hypertension among men. J Am Soc Nephrol 2007; 18: 287-292. (Pubitemid 46053441)
10. Shankar A, Wang JJ, Rochtchina E, Mitchell P. Positive association between plasma fibrinogen level and incident hypertension among men. Hypertension 2006; 48: 1043-1049. (Pubitemid 44772706)
11. Marques-Vidal P, Cambou J-P, Bongard V, Ruidavets J-B, Ferrières J. Systolic and diastolic hypertension: no relationship with lipid and inflammatory markers in Haute-garonne, France. Am J Hypertens 2003; 16: 681-684. (Pubitemid 36900592)
12. Junker R, Heinrich J, Schulte H, Erren M, Assmann G. Hemostasis in normotensive and hypertensive men: results of the PROCAM study. The prospective cardiovascular Munster study. J Hypertens 1998; 16: 913-916.
13. Stefanick ML, Legault C, Tracy RP, Howard G, Craig MK, Lucas DL et al. Distribution and correlates of plasma fibrinogen in middle-aged women. Arterioscler Thromb Vasc Biol 1995; 15: 2085-2093.
14. Nicolosi A. Le indagini di popolazione sulla prevalenza delle principali malattie oculari in Italia. In: Cerulli L, Miglior M, Ponte F (eds). Lepidemiologia oftalmica in Italia. INC: Roma, 1997, pp 43-70.
15. Leite MLC, Nicolosi A. Lifestyle correlates of anthropometric estimates of body adiposity in an Italian middle-aged and elderly population: a covariance analysis. Int J Obes 2006; 30: 926-934. (Pubitemid 43801192)
16. Alberti KG, Zimmet P, Shaw J, IDF epidemiology task force consensus group. The metabolic syndrome-a new worldwide definition. Lancet 2005; 366: 1059-1062. (Pubitemid 41338752)
17. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al., National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 report. JAMA 2003; 289: 2560-2572. (Pubitemid 37430158)
18. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation: Modification of Diet in Renal Disease study group. Ann Intern Med 1999; 130: 461-470. (Pubitemid 29135798)
19. Levey AS, Greene T, Kusek JW, Beck G. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000; 11 (abstract A0828).
20. McCullagh P, Nelder JA. Generalized Linear Models, 2nd edn. Chapman & Hall: London, 1989.
21. Verdecchia P, Angeli F. Natural history of hypertension subtypes. Circulation 2005; 111: 1094-1096. (Pubitemid 40365467)
22. Khattar RS, Swales JD, Dore C, Senior R, Lahiri A. Effect of aging on the prognostic significance of ambulatory systolic, diastolic, and pulse pressure in essential hypertension. Circulation 2001; 104: 783-789. (Pubitemid 32762676)
23. Cigolini M, Targher G, Tonoli M, Manara F, Muggeo M, De Sandre G. Hyperuricaemia: relationships to body fat distribution and other components of the insulin resistance syndrome in 38-year-old healthy men and women. Int J Obes Relat Metab Disord 1995; 19: 92-96.
24. Chu NF, Wang DJ, Liou SH, Shieh SM. Relationship between hyperuricemia and other cardiovascular disease risk factors among adult males in Taiwan. Eur J Epidemiol 2000; 16: 13-17.
25. Brand FN, McGee DL, Kannel WB, Stokes III J, Castelli WP. Hyperuricemia as a risk factor of coronary heart disease: The Framingham Study. Am J Epidemiol 1985; 121: 11-18. (Pubitemid 15150683)
26. Yeh CJ, Pan WH, Jong YS, Kuo YY, Lo CH. Incidence and predictors of isolated systolic hypertension and isolated diastolic hypertension in Taiwan. J Formos Med Assoc 2001; 100: 668-675.
27. Syamala S, Li J, Shankar A. Association between serum uric acid and prehypertension among US adults. J Hypertens 2007; 25: 1583-1589. (Pubitemid 47056563)
28. Johnson RJ, Feig DI, Herrera-Acosta J, Kang DH. Resurrection of uric acid as a causal risk factor in essential hypertension. Hypertension 2005; 45: 18-20. (Pubitemid 40066407)
29. Shankar A, Klein R, Klein BEK, Nieto FJ. The association between serum uric acid level and longterm incidence of hypertension: population-based cohort study. J Hum Hypertens 2006; 20: 937-945. (Pubitemid 44782827)
30. Perlstein TS, Gumieniak O, Williams GH, Sparrow D, Vokonas PS, Gaziano M et al. Uric acid and the development of hypertension. The Normative Aging Study. Hypertension 2006; 48: 1031-1036.
31. Krishnan E, Kwoh CK, Schumacher HR, Kuller L. Hyperuricemia and incidence of hypertension among men without metabolic syndrome. Hypertension 2007; 49: 298-303. (Pubitemid 46143005)
32. Johnson RJ, Rodriguez-Iturbe B, Kang DH, Feig DI, Herrera-Acosta J. A unifying pathway for essential hypertension. Am J Hypertens 2005; 18: 431-440. (Pubitemid 40409928)
33. Mazzali M, Hughes J, Kim YG, Jefferson JA, Kang D-H, Gordon KL et al. Elevated uric acid increases blood pressure in the rat by a novel crystalindependent mechanism. Hypertension 2001; 38: 1101-1106. (Pubitemid 34252813)
34. Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W et al. Hyperuricemia induces endothelial dysfunction. Kidney Int 2005; 67: 1739-1742. (Pubitemid 40577708)
35. Mercuro G, Vitale C, Cerquetani E, Zoncu S, Deidda M, Fini M et al. Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk. Am J Cardiol 2004; 94: 932-935. (Pubitemid 39349561)
36. Perlstein TS, Gumieniak O, Hopkins PN, Murphey LJ, Brown NJ, Williams GH et al. Uric acid and the state of the intrarenal renin-angiotensin system in humans. Kidney Int 2004; 66: 1465-1470. (Pubitemid 39298378)
37. Watanabe S, Kang DH, Feng L, Nakagawa T, Kanellis J, Lan H et al. Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity. Hypertension 2002; 40: 355-360. (Pubitemid 35006723)
38. Blacher J, Safar M. Specific aspects of high blood pressure in the elderly. J Renin Angiotensin Aldosterone Syst 2002; 3(suppl 1): S8-S13.
39. Witteman JCM, Grobbee DE, Walkenburg HA, Burger H, Hofman A, van Hemert AM. J-shaped relation between change in diastolic blood pressure and progression of aortic atherosclerosis. Lancet 1994; 343: 504-507. (Pubitemid 24062283)
40. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999; 340: 115-126.
41. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685-1695.
42. McEniery CM, Wilkinson IB. Large artery stiffness and inflammation. J Hum Hypertens 2005; 19: 507-509. (Pubitemid 40946033)
43. Wakabayashi I, Masuda H. Association of acute-phase reactants with arterial stiffness in patients with type 2 diabetes mellitus. Clin Chim Acta 2006; 365: 230-235. (Pubitemid 43196443)
44. Duprez DA, Somasundaram PE, Sigurdsson G, Hoke L, Florea N, Cohn JN. Relationship between C-reactive protein and arterial stiffness in an asymptomatic population. J Hum Hypertens 2005; 19: 515-519. (Pubitemid 40946035)
45. Vlachopoulos C, Pietri P, Aznaouridis K, Vyssoulis G, Vasiliadou C, Bratsas A et al. Relationship of fibrinogen with arterial stiffness and wave reflections. J Hypertens 2007; 25: 2110-2116. (Pubitemid 47476309)
46. Ciuffetti G, Schillaci G, Lombardini R, Pirro M, Vaudo G, Mannarino E. Plasma viscosity in isolated systolic hypertension: the role of pulse pressure. Am J Hypertens 2005; 18: 1005-1008. (Pubitemid 41040274)
47. Safar ME, Thomas F, Blacher J, Nzietchueng R, Bureau J-M, Pannier B et al. Metabolic syndrome and agerelated progression of aortic stiffness. J Am Coll Cardiol 2006; 47: 72-75. (Pubitemid 43005167)
48. De Silva DA, Woon F-P, Gan H-Y, Cameron J, Kingwell B, Koh T-H et al. Arterial stiffness, metabolic syndrome and inflammation amongst Asian ischaemic stroke patients. Eur J Neurol 2008; 15: 872-875.
49. Roman MJ, Ganau A, Saba PS, Pini R, Pickering TG, Devereux RB. Impact of arterial stiffening on left ventricular structure. Hypertension 2000; 36: 489-494.
50. Zhu Y, Zhang F, Zhang F-C, Wang G, Zhou L. Risk factors related to left ventricular hypertrophy in elderly hypertensive patients. J Chin Clin Med 2006; 1: 308-313.
51. Palmieri V, Tracy RP, Roman MJ, Liu JE, Best LG, Bella JN et al. Relation of left ventricular hypertrophy to inflammation and albuminuria in adults with type 2 diabetes: the strong heart study. Diabetes Care 2003; 26: 2764-2769. (Pubitemid 37205544)
52. Feig DI, Kang D-H, Nakagawa T, Mazzali M, Johnson RJ. Uric acid and hypertension. Curr Hypertens Rep 2006; 8: 111-115. (Pubitemid 43796686)